Copyright © 2008. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00
Significant publications on infectious diseases pharmacotherapy in 2007ROSA F. YEH, PHARM.D., BCPS, is Assistant Professor, Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston (UH), Houston, TX. KRISTI M. KUPER, PHARM.D., BCPS, is Director, Infectious Disease, Clinical Affairs Department, Center for Safety and Clinical Excellence, Cardinal Health, San Diego, CA. ELIZABETH A. COYLE, PHARM.D., BCPS, is Clinical Associate Professor; and KEVIN W. GAREY, PHARM.D., M.S., is Associate Professor and Chair, Department of Clinical Sciences and Administration, College of Pharmacy, UH. JUDY O. IKWUAGWU, B.S., PHARM.D., is Clinical Specialist in Infectious Diseases, Department of Pharmacy Services, The Methodist Hospital (MH), Houston. DAREGO O. MACLAYTON, PHARM.D., BCPS, is Assistant Professor, College of Pharmacy and Health Sciences, Texas Southern University, Houston. JOHN F. MOHR, PHARMD.,. is Clinical Scientific Director, Cubist Pharmaceuticals, Lexington, MA. WILLIAM L. MUSICK, PHARM.D., BCPS, is Clinical Specialist in Infectious Diseases, Department of Pharmacy Services, MH. STEVEN e. PASS, PHARM.D., FCCM, BCPS, is Clinical Associate Professor, Department of Clinical Sciences and Administration, College of Pharmacy, UH. EDGAR RIOS, PHARM.D., BCPS, is Clinical Pharmacist, Infectious Diseases, Department of Pharmacy Services, Memorial Hermann–Texas Medical Center, Houston. VINCENT H. TAM, PHARM.D., BCPS, is Associate Professor, Department of Clinical Sciences and Administration, College of Pharmacy, UH. Address correspondence to Dr. Yeh at the Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, 1441 Moursund Street, Suite 331, Houston, TX 77030 (rfyeh{at}uh.edu).
Summary. On January 2, 2008, the 21 members of the Houston Infectious Disease Network (HIDN) were asked to select an article that was published in a peer-reviewed journal between January 1 and December 31, 2007, and write a summary highlighting why the article was significant to the diagnosis or treatment of ID. Articles were selected based on prior "top 10" presentations at major ID and pharmacy meetings or were listed as major articles in prominent ID journals. Priority was given to peer-reviewed publications and nationally recognized clinical treatment guidelines. Nineteen articles and summaries were submitted by HIDN members. The publication listing was distributed to Society of Infectious Diseases Pharmacists members via an Internet survey in early February 2008. Members were asked to select the 10 most significant articles relating to ID pharmacotherapy from the list of 19 and were allowed to add an additional article that was not already listed. A total of 102 individuals participated in the survey. A listing of the top 10 articles published in 2007 and one honorable mention was compiled, and the significance of each article was summarized.
Conclusion. The increased number of articles in the peer-reviewed medical literature related to the diagnosis and treatment of ID has made it challenging to maintain a contemporary knowledge base of key publications. This summary of significant ID articles published in 2007 can help to alleviate the burden of knowledge management.
Index terms: Communicable diseases; Data collection; Publications
|
|||||||||||||||||||||||